Mylan to Distribute Gilead's Hepatitis C Drugs in India

Mylan’s Indian subsidiary will be the exclusive distributor of Gilead Sciences’s hepatitis C treatments there, in the latest move in the pharmaceutical wars over the market for the liver disease



from WSJ.com: US Business http://ift.tt/1JCZy42

via IFTTT